2013 Q2 Form 10-Q Financial Statement

#000119312513235664 Filed on May 24, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q2
Revenue $892.6M $834.7M $695.5M
YoY Change 28.35% 32.09% 37.89%
Cost Of Revenue $209.0M $183.4M $151.6M
YoY Change 37.9% 34.56% 47.04%
Gross Profit $683.6M $651.3M $543.9M
YoY Change 25.69% 31.43% 35.54%
Gross Profit Margin 76.59% 78.03% 78.21%
Selling, General & Admin $596.2M $548.8M $471.4M
YoY Change 26.49% 30.26% 39.13%
% of Gross Profit 87.22% 84.26% 86.67%
Research & Development $131.9M $121.2M $94.78M
YoY Change 39.21% 50.37% 45.16%
% of Gross Profit 19.3% 18.61% 17.42%
Depreciation & Amortization $62.30M $57.40M $49.40M
YoY Change 26.11% 25.05% 66.89%
% of Gross Profit 9.11% 8.81% 9.08%
Operating Expenses $728.2M $672.1M $566.2M
YoY Change 28.62% 33.88% 40.1%
Operating Profit -$44.54M -$20.81M -$22.25M
YoY Change 100.19% 226.28% 693.76%
Interest Expense $11.88M -$4.300M $6.370M
YoY Change 86.55% 514.29% 44.77%
% of Operating Profit
Other Income/Expense, Net -$2.900M -$900.0K -$700.0K
YoY Change 314.29% 80.0% -12.5%
Pretax Income -$53.94M -$26.00M -$24.87M
YoY Change 116.92% 246.67% -3208.5%
Income Tax $13.78M -$5.200M -$5.393M
% Of Pretax Income
Net Earnings -$67.72M -$20.84M -$19.48M
YoY Change 247.73% 411.13% -3774.53%
Net Earnings / Revenue -7.59% -2.5% -2.8%
Basic Earnings Per Share -$0.12 -$0.04 -$0.04
Diluted Earnings Per Share -$0.12 -$0.04 -$0.04
COMMON SHARES
Basic Shares Outstanding 588.4M shares 146.4M shares 552.6M shares
Diluted Shares Outstanding 588.4M shares 552.6M shares

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.079B $1.758B $710.0M
YoY Change 333.73% 21.5% -7.07%
Cash & Equivalents $1.928B $747.2M $440.8M
Short-Term Investments $1.151B $1.011B $270.0M
Other Short-Term Assets $274.0M $275.0M $241.0M
YoY Change 13.69% 30.33% 57.52%
Inventory
Prepaid Expenses $154.1M $133.3M
Receivables $502.6M $872.6M $371.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.876B $2.016B $1.323B
YoY Change 117.39% 20.55% 11.36%
LONG-TERM ASSETS
Property, Plant & Equipment $623.7M $604.7M $550.0M
YoY Change 13.4% 14.53% 23.32%
Goodwill $1.545B $1.529B
YoY Change 94.73%
Intangibles $50.49M $49.35M
YoY Change 7.04%
Long-Term Investments $1.036B $891.0M $999.0M
YoY Change 3.7% 23.24% 26.46%
Other Assets $190.6M $169.0M $210.0M
YoY Change -9.23% 8.9% 54.41%
Total Long-Term Assets $3.638B $3.513B $2.833B
YoY Change 28.4% 40.98% 46.03%
TOTAL ASSETS
Total Short-Term Assets $2.876B $2.016B $1.323B
Total Long-Term Assets $3.638B $3.513B $2.833B
Total Assets $6.514B $5.529B $4.156B
YoY Change 56.73% 32.78% 32.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.52M $14.54M $20.00M
YoY Change 57.61% -56.3% 17.65%
Accrued Expenses $527.1M $597.7M $400.0M
YoY Change 31.77% 16.68% 35.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $528.0M $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $2.730B $2.918B $1.677B
YoY Change 62.77% 26.85% -0.47%
LONG-TERM LIABILITIES
Long-Term Debt $1.167B $0.00 $502.0M
YoY Change 132.47%
Other Long-Term Liabilities $105.0M $175.7M $125.0M
YoY Change -16.0% -18.64% -25.15%
Total Long-Term Liabilities $1.272B $175.7M $627.0M
YoY Change 102.87% -18.64% 275.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.730B $2.918B $1.677B
Total Long-Term Liabilities $1.272B $175.7M $627.0M
Total Liabilities $4.004B $3.158B $2.346B
YoY Change 70.67% 26.41% 25.32%
SHAREHOLDERS EQUITY
Retained Earnings -$178.7M -$111.0M
YoY Change -169.6%
Common Stock $590.0K $2.411B
YoY Change 1760102.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.463B $2.318B $1.810B
YoY Change
Total Liabilities & Shareholders Equity $6.514B $5.529B $4.156B
YoY Change 56.73% 32.78% 32.86%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q2
OPERATING ACTIVITIES
Net Income -$67.72M -$20.84M -$19.48M
YoY Change 247.73% 411.13% -3774.53%
Depreciation, Depletion And Amortization $62.30M $57.40M $49.40M
YoY Change 26.11% 25.05% 66.89%
Cash From Operating Activities $283.2M $281.6M $213.2M
YoY Change 32.82% 17.19% 52.84%
INVESTING ACTIVITIES
Capital Expenditures $54.01M -$50.50M $44.72M
YoY Change 20.77% 13.23% -263.81%
Acquisitions $22.16M $48.91M
YoY Change -54.69%
Other Investing Activities -$165.3M -$127.8M -$430.3M
YoY Change -61.58% 13.4% -503.28%
Cash From Investing Activities -$219.3M -$178.3M -$475.0M
YoY Change -53.84% 13.35% -698.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.124B 124.4M 97.04M
YoY Change 1057.96% 895.2% 246.56%
NET CHANGE
Cash From Operating Activities $283.2M 281.6M 213.2M
Cash From Investing Activities -$219.3M -178.3M -475.0M
Cash From Financing Activities $1.124B 124.4M 97.04M
Net Change In Cash $1.188B 227.7M -164.7M
YoY Change -820.87% 138.43% -166.72%
FREE CASH FLOW
Cash From Operating Activities $283.2M $281.6M $213.2M
Capital Expenditures $54.01M -$50.50M $44.72M
Free Cash Flow $229.2M $332.1M $168.5M
YoY Change 36.02% 16.57% 1.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
23300000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
440785000
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
590000000 shares
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
119425000
CY2013Q2 us-gaap Goodwill
Goodwill
1544584000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
114569000
CY2013Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
527080000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
10206000
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
134878000
CY2013Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
49572000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
903026000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
25093422 shares
CY2013Q2 us-gaap Acquired Finite Lived Intangible Asset Amount
AcquiredFiniteLivedIntangibleAssetAmount
13854000
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Net Tangible Assets
BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets
2800000
CY2013Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
2110000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
190623000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
2462796000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
142966000
CY2013Q2 us-gaap Other Assets
OtherAssets
37156000
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
1142659000
CY2013Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
979640000
CY2013Q2 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2
442000
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
167533000
CY2013Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
27.31
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
222353000
CY2013Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
137049000
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
27805941 shares
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
205922000
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
11370368 shares
CY2013Q2 us-gaap Prepaid Taxes
PrepaidTaxes
25785000
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
6794000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.55
CY2013Q2 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2
721000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
384080000
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillAmount
16500000
CY2013Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11908000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
60817000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
151534000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5437000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
11370368 shares
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
150229000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
158097000
CY2013Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
11671000
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
171827000
CY2013Q2 us-gaap Liabilities
Liabilities
4003833000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
31522000
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
154114000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
14266000
CY2013Q2 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
143300000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1674797000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
140331000
CY2013Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
49239000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
64861000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178703000
CY2013Q2 us-gaap Assets
Assets
6513709000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.31
CY2013Q2 us-gaap Other Long Term Investments
OtherLongTermInvestments
56207000
CY2013Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1029495000
CY2013Q2 us-gaap Deferred Costs
DeferredCosts
824000
CY2013Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12730000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
11008000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
502609000
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
9529000
CY2013Q2 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
22200000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6513709000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
23658000
CY2013Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
216686000
CY2013Q2 us-gaap Foreign Currency Derivatives At Fair Value Net
ForeignCurrencyDerivativesAtFairValueNet
-220000
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
15351000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
380717000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1927990000
CY2013Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
47080000
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
721000
CY2013Q2 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
431792000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
4044000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
286000
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
44252692 shares
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50494000
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
19358000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
987951000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
27418895 shares
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
13726000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
25358181 shares
CY2013Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
175804532 shares
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Amortizable Intangible Assets
BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets
7700000
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
527080000
CY2013Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
42225000
CY2013Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
321100000
CY2013Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
51400000
CY2013Q2 us-gaap Marketable Securities
MarketableSecurities
1151467000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2729687000
CY2013Q2 us-gaap Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2
279000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27805941 shares
CY2013Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
192429000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
590000
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
58363000
CY2013Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1557305000
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
98524000
CY2013Q2 us-gaap Land
Land
248263000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
2876039000
CY2013Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
527810000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1695448000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
279342000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
623684000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2627183000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
27.23
CY2013Q1 us-gaap Assets
Assets
5528956000
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
2700000
CY2013Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
21.55
CY2013Q2 crm Deferred Commissions Current
DeferredCommissionsCurrent
119499000
CY2013Q2 crm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
0.001
CY2013Q2 crm Computers Equipment And Software
ComputersEquipmentAndSoftware
346280000
CY2013Q2 crm Common Stock Shares Held By Related Parties
CommonStockSharesHeldByRelatedParties
280000 shares
CY2013Q2 crm Accumulated Amortization Relating To Computers Equipment And Software Under Capital Leases
AccumulatedAmortizationRelatingToComputersEquipmentAndSoftwareUnderCapitalLeases
65900000
CY2013Q2 crm Restricted Stock Units Vesting Period
RestrictedStockUnitsVestingPeriod
4 Y
CY2013Q2 crm Deferred Commission Noncurrent
DeferredCommissionNoncurrent
106710000
CY2013Q2 crm Significant Concentration Of Accounts Receivable Number Customers
SignificantConcentrationOfAccountsReceivableNumberCustomers
0 pure
CY2013Q2 crm Options Granted During Period
OptionsGrantedDuringPeriod
149798 shares
CY2013Q2 crm Shares Available For Grant Cancelled During Period
SharesAvailableForGrantCancelledDuringPeriod
137226 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
607284000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
101291000
CY2013Q1 us-gaap Goodwill
Goodwill
1529378000
CY2013Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
597706000
CY2013Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
49572000
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
857609000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
11759740 shares
CY2013Q1 us-gaap Acquired Finite Lived Intangible Asset Amount
AcquiredFiniteLivedIntangibleAssetAmount
13872000
CY2013Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
3522000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168960000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
2317633000
CY2013Q1 us-gaap Other Assets
OtherAssets
20338000
CY2013Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
1005293000
CY2013Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
890664000
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
138165000
CY2013Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
126658000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
311595000
CY2013Q1 us-gaap Prepaid Taxes
PrepaidTaxes
21180000
CY2013Q1 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
7321000
CY2013Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
10064000
CY2013Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
3006000
CY2013Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
120376000
CY2013Q1 us-gaap Liabilities
Liabilities
3157711000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
14535000
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133314000
CY2013Q1 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
136900000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1798640000
CY2013Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
49074000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110982000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.60
CY2013Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
51685000
CY2013Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2013Q1 us-gaap Deferred Costs
DeferredCosts
1077000
CY2013Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
13422000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
872634000
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
7416000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5528956000
CY2013Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
193181000
CY2013Q1 us-gaap Foreign Currency Derivatives At Fair Value Net
ForeignCurrencyDerivativesAtFairValueNet
2336000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
747245000
CY2013Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
53612000
CY2013Q1 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
1669000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
692637000
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
49354000
CY2013Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
19212000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17137000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
597706000
CY2013Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
38275000
CY2013Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
46800000
CY2013Q1 us-gaap Marketable Securities
MarketableSecurities
1011040000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2917624000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
29983292 shares
CY2013Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
207323000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
586000
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
64355000
CY2013Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
521278000
CY2013Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
120341000
CY2013Q1 us-gaap Land
Land
248263000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
2015880000
CY2013Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
521278000
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
252940000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
604669000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2410892000
CY2013Q1 crm Deferred Commissions Current
DeferredCommissionsCurrent
142311000
CY2013Q1 crm Computers Equipment And Software
ComputersEquipmentAndSoftware
328318000
CY2013Q1 crm Accumulated Amortization Relating To Computers Equipment And Software Under Capital Leases
AccumulatedAmortizationRelatingToComputersEquipmentAndSoftwareUnderCapitalLeases
57800000
CY2013Q1 crm Deferred Commission Noncurrent
DeferredCommissionNoncurrent
112082000
CY2013Q1 crm Significant Concentration Of Accounts Receivable Number Customers
SignificantConcentrationOfAccountsReceivableNumberCustomers
0 pure
CY2010Q4 crm Number Of Acquired Acres Of Land
NumberOfAcquiredAcresOfLand
14 acre
CY2013Q2 dei Trading Symbol
TradingSymbol
CRM
CY2013Q2 dei Entity Registrant Name
EntityRegistrantName
SALESFORCE COM INC
CY2013Q2 dei Amendment Flag
AmendmentFlag
false
CY2013Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2013Q2 dei Document Type
DocumentType
10-Q
CY2013Q2 dei Document Period End Date
DocumentPeriodEndDate
2013-04-30
CY2013Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001108524
CY2013Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2013Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2100000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
57700000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44540000
CY2013Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
34300000
CY2013Q2 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Deferred Revenue</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The deferred revenue balance does not represent the total contract value of annual or multi-year, non-cancelable subscription agreements. Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services described above and is recognized as the revenue recognition criteria are met. The Company generally invoices customers in annual or quarterly installments. Deferred revenue is influenced by several factors, including seasonality, the compounding effects of renewals, invoice duration, invoice timing and new business linearity within the quarter.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Deferred revenue that will be recognized during the succeeding twelve month period is recorded as current deferred revenue and the remaining portion is recorded as noncurrent.</font></p> </div>
CY2013Q2 us-gaap Trading Securities Realized Gain
TradingSecuritiesRealizedGain
638000
CY2013Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-4039000
CY2013Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-628000
CY2013Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22161000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71132000
CY2013Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14558000
CY2013Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y
CY2013Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
30800000
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
114729000
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
41.79
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
27.37
CY2013Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-95808000
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-67721000
CY2013Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2189923 shares
CY2013Q2 us-gaap Investment Income Net
InvestmentIncomeNet
3354000
CY2013Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Concentrations of Credit Risk and Significant Customers</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company&#x2019;s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and trade accounts receivable. Although the Company deposits its cash with multiple financial institutions, its deposits, at times, may exceed federally insured limits. Collateral is not required for accounts receivable. The Company maintains an allowance for doubtful accounts receivable balances. The allowance is based upon historical loss patterns, the number of days that billings are past due and an evaluation of the potential risk of loss associated with delinquent accounts.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">No customer accounted for more than five percent of accounts receivable at April&#xA0;30, 2013 and January&#xA0;31, 2013, respectively. No single customer accounted for five percent or more of total revenue during the three months ended April&#xA0;30, 2013 and 2012.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Geographic Locations</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As of April&#xA0;30, 2013 and January&#xA0;31, 2013, assets located outside the Americas were 13 percent and 16 percent of total assets, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Revenues by geographical region are as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="82%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Three Months Ended<br /> April&#xA0;30,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom">&#xA0;<font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Americas</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">631,108</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">484,953</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Europe</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">162,826</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">118,294</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Asia Pacific</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">92,220</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">892,633</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">695,467</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Approximately 95 percent and 94 percent of the Americas revenue for the three months ended April&#xA0;30, 2013 and 2012, respectively, is attributed to the United States.</font></p> </div>
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
62297000
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.26 pure
CY2013Q2 us-gaap Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
1000000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
129750000
CY2013Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1522000
CY2013Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
66524000
CY2013Q2 us-gaap Trading Securities Realized Loss
TradingSecuritiesRealizedLoss
681000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
42.47
CY2013Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
283189000
CY2013Q2 us-gaap Fiscal Period
FiscalPeriod
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Fiscal Year</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company&#x2019;s fiscal year ends on January&#xA0;31. References to fiscal 2014, for example, refer to the fiscal year ending January&#xA0;31, 2014.</font></p> </div>
CY2013Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-219276000
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3397000
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
874000
CY2013Q2 us-gaap Goodwill Other Changes
GoodwillOtherChanges
1290000
CY2013Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-129835000
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.54
CY2013Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
741000
CY2013Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54010000
CY2013Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1180745000
CY2013Q2 us-gaap Cost Of Services Licenses And Maintenance Agreements
CostOfServicesLicensesAndMaintenanceAgreements
8000000
CY2013Q2 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
84800000
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
588385000 shares
CY2013Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9670000
CY2013Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y
CY2013Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-369889000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-53943000
CY2013Q2 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
53900000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
466490000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3411000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
131939000
CY2013Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1123641000
CY2013Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7872000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1721000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
208994000
CY2013Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
45667000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-5760000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
137226 shares
CY2013Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
264287000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
728179000
CY2013Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1866000
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
588385000 shares
CY2013Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y2M12D
CY2013Q2 us-gaap Revenues
Revenues
892633000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
50412000
CY2013Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17283000
CY2013Q2 us-gaap Gross Profit
GrossProfit
683639000
CY2013Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
111740000
CY2013Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8499000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q2 us-gaap Interest Paid
InterestPaid
642000
CY2013Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9240000
CY2013Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On March 20, 2013, the Company's certificate of incorporation was amended to increase the number of authorized shares of common stock from 400.0 million to 1.6 billion in order to provide for a four-for-one stock split of the common stock effected in the form of a stock dividend.
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-67721000
CY2013Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1866000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
149798 shares
CY2013Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16496000
CY2013Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1132750000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13778000
CY2013Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6809000
CY2013Q2 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the Company&#x2019;s condensed consolidated financial statements and notes thereto.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Significant estimates and assumptions made by management include the determination of:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the best estimate of selling price of the deliverables included in multiple-deliverable revenue arrangements,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the assessment of recoverability of long-lived assets (property and equipment, goodwill and identified intangibles),</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the fair value of assets acquired and liabilities assumed for business combinations,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the recognition, measurement and valuation of current and deferred income taxes,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the recognition and measurement of loss contingencies,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the fair value of stock awards issued,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the valuation of strategic investments and the determination of other-than-temporary impairments, and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the effective imputed interest rates for similar notes payables that did not have a convertible feature, and which was used in the determination of the liability component of the Convertible Senior Notes.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Actual results could differ materially from those estimates.</font></p> </div>
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000
CY2013Q2 us-gaap Interest Expense
InterestExpense
11883000
CY2013Q2 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
11396000
CY2013Q2 crm Subscription And Support Revenue
SubscriptionAndSupportRevenue
842221000
CY2013Q2 crm Cost Of Revenue Subscription And Support
CostOfRevenueSubscriptionAndSupport
153550000
CY2013Q2 crm Supplemental Assets Acquired Under Capital Leases
SupplementalAssetsAcquiredUnderCapitalLeases
6557000
CY2013Q2 crm Estimated Unrecognized Tax Benefits Period Increase Decrease
EstimatedUnrecognizedTaxBenefitsPeriodIncreaseDecrease
3000000
CY2013Q2 crm Convertible Senior Notes Shares
ConvertibleSeniorNotesShares
44247536 shares
CY2013Q2 crm Percentage Of Customer Total Revenue Required To Be Considered Significant Customer
PercentageOfCustomerTotalRevenueRequiredToBeConsideredSignificantCustomer
0.05 pure
CY2013Q2 crm Notes Trading Price Percentage
NotesTradingPricePercentage
0.98 pure
CY2013Q2 crm Contractual Life Of Stock Options In Years
ContractualLifeOfStockOptionsInYears
5 Y
CY2013Q2 crm Land Activity And Building Improvements
LandActivityAndBuildingImprovements
0
CY2013Q2 crm Percentage Of Customer Accounts Receivable Required To Be Considered Significant Customer
PercentageOfCustomerAccountsReceivableRequiredToBeConsideredSignificantCustomer
0.05 pure
CY2013Q2 crm Shares Available For Grant Exercised
SharesAvailableForGrantExercised
0 shares
CY2013Q2 crm Holders Of Notes Conversion Percentage Of Conversion Price
HoldersOfNotesConversionPercentageOfConversionPrice
1.30 pure
CY2013Q2 crm Number Of Consecutive Trading Days In Period
NumberOfConsecutiveTradingDaysInPeriod
30 D
CY2013Q2 crm Prior Contractual Life Of Stock Options In Years
PriorContractualLifeOfStockOptionsInYears
10 Y
CY2013Q2 crm Significant Concentration Of Total Revenue Number Customers
SignificantConcentrationOfTotalRevenueNumberCustomers
0 pure
CY2013Q2 crm Number Of Days Out Of Thirty That Common Stock Price Exceeded Conversion Price
NumberOfDaysOutOfThirtyThatCommonStockPriceExceededConversionPrice
20 D
CY2013Q2 crm Contractual Interest Expense
ContractualInterestExpense
1415000
CY2013Q2 crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
5116000
CY2013Q2 crm Percentage Of Purchase Price Of Notes Which Should Be Paid Upon Fundamental Change
PercentageOfPurchasePriceOfNotesWhichShouldBePaidUponFundamentalChange
1.00 pure
CY2013Q2 crm Cost Of Service Revenue
CostOfServiceRevenue
55444000
CY2013Q2 crm Closing Price Of Common Stock
ClosingPriceOfCommonStock
41.11
CY2013Q2 crm Increase Decrease Deferred Commissions
IncreaseDecreaseDeferredCommissions
17483000
CY2013Q2 crm Payment For Note Hedge
PaymentForNoteHedge
153800000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
127100000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22249000
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
25100000
CY2012Q2 us-gaap Trading Securities Realized Gain
TradingSecuritiesRealizedGain
91000
CY2012Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-2068000
CY2012Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
418000
CY2012Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
48913000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21961000
CY2012Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
37699000
CY2012Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2012Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
22400000
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
81266000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2012Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-144260000
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-19475000
CY2012Q2 us-gaap Investment Income Net
InvestmentIncomeNet
4461000
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
49441000
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22 pure
CY2012Q2 us-gaap Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
1200000
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
213212000
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-474987000
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4749000
CY2012Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
710000
CY2012Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-45580000
CY2012Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
330000
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44721000
CY2012Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-166499000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101600000
CY2012Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1755000
CY2012Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
93567000
CY2012Q2 us-gaap Trading Securities Realized Loss
TradingSecuritiesRealizedLoss
379000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.23
CY2012Q2 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
552600000 shares
CY2012Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4669000
CY2012Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2012Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-312660000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24868000
CY2012Q2 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
24900000
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
369789000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2486000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
94776000
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97036000
CY2012Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20349000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1120000
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
151551000
CY2012Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
36246000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-3188000
CY2012Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
487803000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
566165000
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
11043000
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
552600000 shares
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012Q2 us-gaap Revenues
Revenues
695467000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
40247000
CY2012Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41961000
CY2012Q2 us-gaap Gross Profit
GrossProfit
543916000
CY2012Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
75522000
CY2012Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
7574000
CY2012Q2 us-gaap Interest Paid
InterestPaid
624000
CY2012Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6177000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-19475000
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
11043000
CY2012Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5393000
CY2012Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1760000
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2012Q2 us-gaap Interest Expense
InterestExpense
6370000
CY2012Q2 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
7585000
CY2012Q2 crm Subscription And Support Revenue
SubscriptionAndSupportRevenue
655220000
CY2012Q2 crm Cost Of Revenue Subscription And Support
CostOfRevenueSubscriptionAndSupport
108744000
CY2012Q2 crm Supplemental Assets Acquired Under Capital Leases
SupplementalAssetsAcquiredUnderCapitalLeases
6874000
CY2012Q2 crm Noncash Or Part Noncash Acquisition Stock Acquired
NoncashOrPartNoncashAcquisitionStockAcquired
2204000
CY2012Q2 crm Percentage Of Customer Total Revenue Required To Be Considered Significant Customer
PercentageOfCustomerTotalRevenueRequiredToBeConsideredSignificantCustomer
0.05 pure
CY2012Q2 crm Land Activity And Building Improvements
LandActivityAndBuildingImprovements
4106000
CY2012Q2 crm Holders Of Notes Conversion Percentage Of Conversion Price
HoldersOfNotesConversionPercentageOfConversionPrice
1.30 pure
CY2012Q2 crm Number Of Consecutive Trading Days In Period
NumberOfConsecutiveTradingDaysInPeriod
30 D
CY2012Q2 crm Significant Concentration Of Total Revenue Number Customers
SignificantConcentrationOfTotalRevenueNumberCustomers
0 pure
CY2012Q2 crm Number Of Days Out Of Thirty That Common Stock Price Exceeded Conversion Price
NumberOfDaysOutOfThirtyThatCommonStockPriceExceededConversionPrice
20 D
CY2012Q2 crm Contractual Interest Expense
ContractualInterestExpense
1078000
CY2012Q2 crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
2665000
CY2012Q2 crm Cost Of Service Revenue
CostOfServiceRevenue
42807000
CY2012Q2 crm Increase Decrease Deferred Commissions
IncreaseDecreaseDeferredCommissions
32118000
CY2012Q2 crm Payment For Note Hedge
PaymentForNoteHedge
0
CY2013Q1 crm Percentage Of Customer Accounts Receivable Required To Be Considered Significant Customer
PercentageOfCustomerAccountsReceivableRequiredToBeConsideredSignificantCustomer
0.05 pure

Files In Submission

Name View Source Status
R43.htm Edgar Link pending
0001193125-13-235664-index-headers.html Edgar Link pending
0001193125-13-235664-index.html Edgar Link pending
0001193125-13-235664.txt Edgar Link pending
0001193125-13-235664-xbrl.zip Edgar Link pending
crm-20130430.xml Edgar Link completed
crm-20130430.xsd Edgar Link pending
crm-20130430_cal.xml Edgar Link unprocessable
crm-20130430_def.xml Edgar Link unprocessable
crm-20130430_lab.xml Edgar Link unprocessable
crm-20130430_pre.xml Edgar Link unprocessable
d511576d10q.htm Edgar Link pending
d511576dex311.htm Edgar Link pending
d511576dex312.htm Edgar Link pending
d511576dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending